FDA Grants Priority Review for Madrigal Pharma’s Non-Alcoholic Steatohepatitis (NASH) Treatment
Madrigal Pharmaceuticals, a leading clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for nonalcoholic steatohepatitis (NASH), has exciting news to share. The U.S. ...